MDK(SH:688079)2022-10-27 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥116,618,568.46, representing a year-on-year increase of 6.38%[5] - The net profit attributable to shareholders for Q3 2022 was ¥4,454,519.76, showing a significant decline of 81.19% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥5,392,720.87, down 78.15% year-on-year[6] - The basic earnings per share for Q3 2022 was ¥0.01, a decrease of 83.33% compared to the previous year[6] - The company's net profit for the year-to-date was ¥8,801,370.96, down 87.64% compared to the same period last year[5] - Net profit for the third quarter of 2022 was ¥7,205,408.78, a significant decrease from ¥71,311,580.67 in the same quarter of 2021, reflecting a decline of approximately 89.9%[22] - The total comprehensive income for the period attributable to the parent company was CNY 9,202,302.91, compared to CNY 71,162,251.56 in the previous period, indicating a significant decrease[23] - Basic and diluted earnings per share for the current period were CNY 0.02, down from CNY 0.19 in the previous period[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,882,461,268.85, an increase of 4.07% from the end of the previous year[6] - As of September 30, 2022, the company's total current assets amounted to ¥540,083,430.62, a decrease from ¥788,146,747.74 as of December 31, 2021, representing a decline of approximately 31.5%[17] - The total assets as of the end of the third quarter of 2022 were ¥1,882,461,268.85, compared to ¥1,808,791,090.39 at the end of the same period in 2021, showing an increase of approximately 4.1%[19] - Total liabilities at the end of the third quarter of 2022 were ¥303,184,975.84, up from ¥201,249,141.30 in 2021, indicating a rise of about 50.5%[19] - The total liabilities of the company as of September 30, 2022, were not specified in the provided data, but the trend in current assets suggests a need for careful monitoring of financial health[17] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥156,580,838.62, reflecting an increase of 8.60%[6] - The net cash flow from operating activities for the first three quarters was CNY 156,580,838.62, up from CNY 144,176,438.28 in the same period last year, reflecting a growth of approximately 9.3%[25] - Cash inflow from operating activities totaled CNY 678,103,942.58, while cash outflow was CNY 521,523,103.96, resulting in a net cash flow of CNY 156,580,838.62[25] - The company reported a net cash outflow from investing activities of CNY -257,450,919.50, an improvement from CNY -485,850,605.87 in the previous year[26] - Cash inflow from financing activities was CNY 267,271,051.41, down from CNY 1,014,916,263.06 in the previous period, indicating a decrease of approximately 73.7%[26] - The company’s cash and cash equivalents at the end of the period were CNY 358,593,464.28, compared to CNY 401,793,405.12 at the end of the previous period[26] Research and Development - Research and development expenses totaled ¥20,541,334.41, up 24.92% year-on-year, accounting for 17.61% of operating revenue[6] - Research and development expenses for the first three quarters of 2022 amounted to ¥53,325,917.83, up from ¥46,962,860.33 in 2021, marking an increase of about 13.0%[21] Shareholder Information - The report indicates that the top ten shareholders do not participate in margin trading or securities lending, ensuring stability in shareholder structure[15] Other Information - The company has not disclosed any new product developments or technological advancements in the current report[16] - There are no significant mergers or acquisitions reported during the quarter[16] - The company has not provided specific future guidance or market expansion strategies in the current report[16] - The company reported a decrease in financial expenses due to exchange losses, contributing to the decline in net profit[10] - The company experienced a loss in fair value changes amounting to -¥8,616,690.26, compared to -¥2,434,159.22 in the previous year, reflecting a worsening of approximately 254.5%[22] - The company's cash and cash equivalents were reported at ¥376,791,443.51, down from ¥424,561,309.71, indicating a decrease of about 11.2%[17] - Accounts receivable decreased to ¥42,207,791.74 from ¥48,428,273.30, reflecting a reduction of approximately 12.5%[17] - Inventory increased to ¥70,734,270.13 from ¥65,904,060.06, showing an increase of about 7.0%[17] - The company reported no trading financial assets as of September 30, 2022, compared to ¥201,248,604.77 at the end of 2021, indicating a complete divestment in this area[17] - The company's cash and cash equivalents increased to ¥97,612.70 from ¥122,214.64 year-over-year, reflecting a decrease of approximately 20.0%[19] - The company reported a significant increase in fixed assets, totaling ¥814,338,103.94, compared to ¥709,300,461.24 in the previous year, representing a growth of about 14.8%[19] - The total equity attributable to shareholders was ¥1,536,083,709.98, a decrease from ¥1,577,589,377.53 in the previous year, indicating a decline of approximately 2.6%[19] - The company received CNY 79,547,542.60 in tax refunds, compared to CNY 99,795,717.22 in the previous year, showing a decrease of approximately 20.3%[25] - The total cash outflow for purchasing goods and services was CNY 146,471,416.93, down from CNY 180,984,575.76 in the previous year[25] - The company reported a significant increase in cash outflow for investing in fixed assets, which rose to CNY 435,828,278.98 from CNY 234,840,075.68 in the previous year[26]